Astrocyte-specific deletion of the mitochondrial m-AAA protease reveals glial contribution to neurodegeneration.


Journal

Glia
ISSN: 1098-1136
Titre abrégé: Glia
Pays: United States
ID NLM: 8806785

Informations de publication

Date de publication:
08 2019
Historique:
received: 20 08 2018
revised: 02 04 2019
accepted: 04 04 2019
pubmed: 17 4 2019
medline: 11 2 2020
entrez: 17 4 2019
Statut: ppublish

Résumé

Mitochondrial dysfunction causes neurodegeneration but whether impairment of mitochondrial homeostasis in astrocytes contributes to this pathological process remains largely unknown. The m-AAA protease exerts quality control and regulatory functions crucial for mitochondrial homeostasis. AFG3L2, which encodes one of the subunits of the m-AAA protease, is mutated in spinocerebellar ataxia SCA28 and in infantile syndromes characterized by spastic-ataxia, epilepsy and premature death. Here, we investigate the role of Afg3l2 and its redundant homologue Afg3l1 in the Bergmann glia (BG), radial astrocytes of the cerebellum that have functional connections with Purkinje cells (PC) and regulate glutamate homeostasis. We show that astrocyte-specific deletion of Afg3l2 in the mouse leads to late-onset motor impairment and to degeneration of BG, which display aberrant morphology, altered expression of the glutamate transporter EAAT2, and a reactive inflammatory signature. The neurological and glial phenotypes are drastically exacerbated when astrocytes lack both Afg31l and Afg3l2, and therefore, are totally depleted of the m-AAA protease. Moreover, mitochondrial stress responses and necroptotic markers are induced in the cerebellum. In both mouse models, targeted BG show a fragmented mitochondrial network and loss of mitochondrial cristae, but no signs of respiratory dysfunction. Importantly, astrocyte-specific deficiency of Afg3l1 and Afg3l2 triggers secondary morphological degeneration and electrophysiological changes in PCs, thus demonstrating a non-cell-autonomous role of glia in neurodegeneration. We propose that astrocyte dysfunction amplifies both neuroinflammation and glutamate excitotoxicity in patients carrying mutations in AFG3L2, leading to a vicious circle that contributes to neuronal death.

Identifiants

pubmed: 30989755
doi: 10.1002/glia.23626
pmc: PMC6618114
doi:

Substances chimiques

ATP-Dependent Proteases EC 3.4.21.-
Afg3l1 protein, mouse EC 3.4.24.-
Afg3l2 protein, mouse EC 3.4.24.-
Metalloendopeptidases EC 3.4.24.-
ATPases Associated with Diverse Cellular Activities EC 3.6.4.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1526-1541

Informations de copyright

© 2019 The Authors. Glia published by Wiley Periodicals, Inc.

Références

Nat Neurosci. 2007 Nov;10(11):1387-94
pubmed: 17965659
Mol Cell Biol. 2007 Jan;27(2):758-67
pubmed: 17101804
J Neurosci. 2008 Mar 12;28(11):2827-36
pubmed: 18337413
J Neurosci. 2009 Jul 22;29(29):9244-54
pubmed: 19625515
Mol Cell. 2016 Oct 6;64(1):148-162
pubmed: 27642048
Nat Genet. 2010 Apr;42(4):313-21
pubmed: 20208537
J Neurosci. 2017 Apr 19;37(16):4231-4242
pubmed: 28314814
EMBO J. 2012 Mar 21;31(6):1336-49
pubmed: 22354038
Science. 2016 Aug 5;353(6299):603-8
pubmed: 27493188
Nat Commun. 2018 Jan 4;9(1):70
pubmed: 29302033
Acta Neuropathol. 2010 Jan;119(1):7-35
pubmed: 20012068
Elife. 2017 Nov 14;6:
pubmed: 29132502
Cell Metab. 2016 Apr 12;23(4):635-48
pubmed: 26924217
Cell. 1998 Jun 12;93(6):973-83
pubmed: 9635427
Cerebellum. 2012 Sep;11(3):630-9
pubmed: 20480274
Biochem Soc Trans. 2014 Oct;42(5):1302-10
pubmed: 25233407
Neuron. 2014 Mar 5;81(5):1001-1008
pubmed: 24508385
J Vis Exp. 2010 May 21;(39):
pubmed: 20495529
J Neurosci. 2014 Sep 3;34(36):11929-47
pubmed: 25186741
Pediatr Neurol. 2017 Jun;71:24-28
pubmed: 28449981
Cerebellum. 2006;5(2):116-26
pubmed: 16818386
Nature. 2017 Jan 26;541(7638):481-487
pubmed: 28099414
Nat Rev Neurosci. 2017 Jan;18(1):31-41
pubmed: 27904142
Nat Rev Mol Cell Biol. 2018 Feb;19(2):77-92
pubmed: 28792006
Glia. 2015 Nov;63(11):1966-1981
pubmed: 26037411
J Mol Endocrinol. 2008 Nov;41(5):289-300
pubmed: 18753308
Nat Rev Neurosci. 2004 Aug;5(8):641-55
pubmed: 15263894
IUBMB Life. 2011 Oct;63(10):816-23
pubmed: 21901813
Nature. 2015 Jan 15;517(7534):311-20
pubmed: 25592536
PLoS Genet. 2016 Dec 2;12(12):e1006463
pubmed: 27911893
Hum Mutat. 2010 Oct;31(10):1117-24
pubmed: 20725928
Hum Mol Genet. 2009 Jun 1;18(11):2001-13
pubmed: 19289403
Stem Cells. 2009 May;27(5):1152-63
pubmed: 19418461
Sci Rep. 2017 Oct 25;7(1):13988
pubmed: 29070875
J Neurosci. 2012 May 2;32(18):6391-410
pubmed: 22553043
Cell Rep. 2018 Aug 7;24(6):1407-1414
pubmed: 30089252
Anat Embryol (Berl). 1983;167(2):203-11
pubmed: 6614505
Cell Rep. 2017 Jun 27;19(13):2718-2729
pubmed: 28658620
PLoS Genet. 2011 Oct;7(10):e1002325
pubmed: 22022284
Transgenic Res. 2008 Oct;17(5):919-28
pubmed: 18483774
Nat Neurosci. 2006 Oct;9(10):1302-11
pubmed: 16936724
Neurology. 2014 Jun 10;82(23):2092-100
pubmed: 24814845
Cell Metab. 2017 Aug 1;26(2):419-428.e5
pubmed: 28768179
Nat Rev Mol Cell Biol. 2001 Aug;2(8):589-98
pubmed: 11483992
Cell Metab. 2011 Dec 7;14(6):724-38
pubmed: 22152301
J Clin Invest. 2015 Jan;125(1):263-74
pubmed: 25485680
Nature. 2005 Jan 6;433(7021):73-7
pubmed: 15635412
Cell Res. 2018 Mar;28(3):296-306
pubmed: 29451229
Nature. 2016 Dec 1;540(7631):124-128
pubmed: 27819681
Genomics. 1999 Jul 1;59(1):51-8
pubmed: 10395799
Cold Spring Harb Perspect Biol. 2015 Feb 06;7(9):a020370
pubmed: 25663667
Trends Immunol. 2018 Feb;39(2):123-134
pubmed: 29236673
Genomics. 2001 Aug;76(1-3):58-65
pubmed: 11549317
Brain. 2006 Jan;129(Pt 1):235-42
pubmed: 16251216
Science. 2001 May 4;292(5518):926-9
pubmed: 11340205
J Clin Invest. 2012 Nov;122(11):4048-58
pubmed: 23041622
Proc Natl Acad Sci U S A. 2011 Aug 2;108(31):12937-42
pubmed: 21768369
Glia. 2019 Aug;67(8):1526-1541
pubmed: 30989755
Front Cell Neurosci. 2015 Jul 02;9:246
pubmed: 26190972
Hum Mol Genet. 2012 Sep 1;21(17):3858-70
pubmed: 22678058

Auteurs

Sara Murru (S)

Department of Biology, Institute for Genetics, University of Cologne, Cologne, Germany.
Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.

Simon Hess (S)

Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.
Department of Biology, Institute for Zoology, Biocenter, University of Cologne, Cologne, Germany.

Esther Barth (E)

Department of Biology, Institute for Genetics, University of Cologne, Cologne, Germany.
Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.

Eva R Almajan (ER)

Department of Biology, Institute for Genetics, University of Cologne, Cologne, Germany.
Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.

Désirée Schatton (D)

Department of Biology, Institute for Genetics, University of Cologne, Cologne, Germany.
Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.

Steffen Hermans (S)

Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.

Susanne Brodesser (S)

Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.

Thomas Langer (T)

Department of Mitochondrial Proteostasis, Max-Planck-Institute for Biology of Ageing, Cologne, Germany.

Peter Kloppenburg (P)

Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.
Department of Biology, Institute for Zoology, Biocenter, University of Cologne, Cologne, Germany.

Elena I Rugarli (EI)

Department of Biology, Institute for Genetics, University of Cologne, Cologne, Germany.
Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH